stdClass Object
(
    [id] => YaUOTxUAACoAAOKq
    [uid] => nec
    [url] => 
    [type] => lawsuits
    [href] => https://medtruth.cdn.prismic.io/api/v2/documents/search?ref=YfQyHhEAACIA3aD4&q=%5B%5B%3Ad+%3D+at%28document.id%2C+%22YaUOTxUAACoAAOKq%22%29+%5D%5D
    [tags] => Array
        (
        )

    [first_publication_date] => 2021-12-03T17:35:39+0000
    [last_publication_date] => 2021-12-03T17:35:39+0000
    [slugs] => Array
        (
            [0] => necrotizing-enterocolitis-nec
        )

    [linked_documents] => Array
        (
        )

    [lang] => en-us
    [alternate_languages] => Array
        (
        )

    [data] => stdClass Object
        (
            [title] => NEC
            [page_heading] => Array
                (
                    [0] => stdClass Object
                        (
                            [type] => heading1
                            [text] => Necrotizing Enterocolitis (NEC)
                            [spans] => Array
                                (
                                )

                        )

                )

            [header_description] => Array
                (
                    [0] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => 
                            [spans] => Array
                                (
                                )

                        )

                )

            [page_content] => Array
                (
                    [0] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => Enfamil was introduced by Mead Johnson in 1964 as an alternative to natural human breast milk. Similac was originally introduced by Abbott Labs in 1925. In addition to breast milk alternatives for infants, these companies began to sell a formula designed for premature infants. This premature formula is used by doctors in hospitals, including the neonatal intensive unit (NICU). 
                            [spans] => Array
                                (
                                )

                        )

                    [1] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => While synthetic infant milk can be a useful alternative for breast milk and help mothers and babies alike, some infants have suffered serious side effects from these products.
                            [spans] => Array
                                (
                                )

                        )

                )

            [page_content_2] => Array
                (
                    [0] => stdClass Object
                        (
                            [type] => heading2
                            [text] => Side Effects & Complications
                            [spans] => Array
                                (
                                    [0] => stdClass Object
                                        (
                                            [start] => 0
                                            [end] => 28
                                            [type] => strong
                                        )

                                )

                        )

                    [1] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => When used without being mixed with human breast milk or other milk products, there can be serious issues that arise from Enfamil and Similac. One of the most serious side effects that have been reported is necrotizing enterocolitis (NEC).
                            [spans] => Array
                                (
                                )

                        )

                    [2] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => NEC is a gastrointestinal condition that affects premature infants. It inflames the infant’s intestinal tissue, causing it to die. It can create holes in the intestines which allow bacteria to escape into the body, causing septic infection and potentially death. According to Cleveland Clinic, 9 in 10 infants with NEC are premature and are fed through a feeding tube in the stomach.
                            [spans] => Array
                                (
                                )

                        )

                    [3] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => These effects can endanger the life of the infant whose premature or immunocompromised body may be unable to recover from these issues. Compounding the issue, if the premature infant was fed this formula in the NICU, then the parents may not find out until it’s too late.
                            [spans] => Array
                                (
                                )

                        )

                )

            [page_content_3] => Array
                (
                    [0] => stdClass Object
                        (
                            [type] => heading2
                            [text] => Legal actions
                            [spans] => Array
                                (
                                    [0] => stdClass Object
                                        (
                                            [start] => 0
                                            [end] => 13
                                            [type] => strong
                                        )

                                )

                        )

                    [1] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => Lawsuits alleging that Abbott Labs and Mead Johnson were negligent in the production of their baby food have been active since 2020. In January 2021, a judge denied a motion to dismiss the case of 48-day-old Tylea Hundley, and other lawsuits have been filed nationwide since June 2021. At this time, there is not a multidistrict litigation (MDL) in motion.  
                            [spans] => Array
                                (
                                )

                        )

                    [2] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => As lawsuits continue to unfold and more patients join the litigation, settlements and verdicts will begin to give patients, attorneys, Abbott Labs and Mead Johnson a better idea of the true scale of the injuries that have been inflicted on patients.
                            [spans] => Array
                                (
                                )

                        )

                )

            [page_content_4] => Array
                (
                    [0] => stdClass Object
                        (
                            [type] => heading2
                            [text] => The Next Steps
                            [spans] => Array
                                (
                                    [0] => stdClass Object
                                        (
                                            [start] => 0
                                            [end] => 14
                                            [type] => strong
                                        )

                                )

                        )

                    [1] => stdClass Object
                        (
                            [type] => list-item
                            [text] => Fill out a free case review
                            [spans] => Array
                                (
                                )

                        )

                    [2] => stdClass Object
                        (
                            [type] => list-item
                            [text] => Our support team will follow up
                            [spans] => Array
                                (
                                )

                        )

                    [3] => stdClass Object
                        (
                            [type] => list-item
                            [text] => If eligible, sign a contingency agreement
                            [spans] => Array
                                (
                                )

                        )

                )

            [section_5_left_image] => stdClass Object
                (
                    [dimensions] => stdClass Object
                        (
                            [width] => 1000
                            [height] => 500
                        )

                    [alt] => 
                    [copyright] => 
                    [url] => https://images.prismic.io/medtruth/2675e108-8c59-4282-a4b8-7ae739c66f76_MedTruth+Legal+Developments+Coverage+Area.png?auto=compress,format
                )

            [section_5_right_content] => Array
                (
                    [0] => stdClass Object
                        (
                            [type] => heading2
                            [text] => What to Expect
                            [spans] => Array
                                (
                                    [0] => stdClass Object
                                        (
                                            [start] => 0
                                            [end] => 14
                                            [type] => strong
                                        )

                                )

                        )

                    [1] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => Patients who have suffered from a dangerous product can be overwhelmed by the possibilities a lawsuit may bring. After seeking legal counsel patients can expect to be interviewed in the weeks following their submission where their case is reviewed by an expert.
                            [spans] => Array
                                (
                                )

                        )

                    [2] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => If the case fits the firm’s criteria, the case can be accepted and the long road to recovery can begin. During the periods of discovery and pretrial motions, the patient may be consulted to provide their testimony or not consulted at all. Following these events, the patient will likely not need to contribute to the case unless it is to weigh in on whether to accept a settlement.  
                            [spans] => Array
                                (
                                )

                        )

                    [3] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => The firms that MedTruth partners with will not require an up-front fee, but will instead work on contingency, only taking payment from the verdict or settlement that is won or taking nothing at all. While these cases may last years, patients are advised not to sign with other firms as the ongoing case is still being handled by their current law firm. Patients unsure about the status of their case can call their firm for updates periodically. For this reason, it is suggested that after having their case taken, patients should record the information about their case and firm in a safe place.
                            [spans] => Array
                                (
                                )

                        )

                )

            [section_6_left_content] => Array
                (
                    [0] => stdClass Object
                        (
                            [type] => heading2
                            [text] => How We Can Help
                            [spans] => Array
                                (
                                    [0] => stdClass Object
                                        (
                                            [start] => 0
                                            [end] => 15
                                            [type] => strong
                                        )

                                )

                        )

                    [1] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => While MedTruth is not funded or operated by law firms, as an advocacy resource we are not neutral either: we will seek to inform patients about the legal actions taken against negligent corporations and to lead patients seeking justice to those who can provide it. While awareness of side effects and harmful products is the first step, MedTruth stands firmly with the idea that every wronged patient deserves their day in court.
                            [spans] => Array
                                (
                                )

                        )

                    [2] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => Putting that ideal into action, MedTruth has forged connections with top law firms in order to put harmed patients on the path to justice. These firms do not influence MedTruth’s editorial direction; rather, they are one of a myriad of tools that allows MedTruth to realize its mission through concrete actions. MedTruth strives to be the intersection of patient advocacy, news information and legal action. These three pillars are delicately balanced to ensure that all interests are represented.
                            [spans] => Array
                                (
                                )

                        )

                )

            [header_image] => stdClass Object
                (
                    [dimensions] => stdClass Object
                        (
                            [width] => 3120
                            [height] => 2080
                        )

                    [alt] => 
                    [copyright] => 
                    [url] => https://images.prismic.io/medtruth/6e6ead50-464b-4780-9355-50874dbc2ee6_Bayer+Settlement+Bid.jpg?auto=compress,format
                )

            [meta_title] => 
            [meta_description] => 
            [meta_image] => stdClass Object
                (
                )

            [introduced] => Array
                (
                    [0] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => 1959 (Enfamil) / 1925 (Similac)
                            [spans] => Array
                                (
                                )

                        )

                )

            [treats] => Array
                (
                    [0] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => Synthetic Infant Milk
                            [spans] => Array
                                (
                                )

                        )

                )

            [side_effects] => Array
                (
                    [0] => stdClass Object
                        (
                            [type] => paragraph
                            [text] => Preterm infants have suffered gastrointestinal issues including necrotizing enterocolitis and death.
                            [spans] => Array
                                (
                                )

                        )

                )

        )

)
SINGLE